Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arcutis Biotherapeutics, Inc. (ARQT)  
$8.60 0.24 (2.71%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 106,469,000
Market Cap: 915.63(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.84 - $14.82
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    : 8
Insider 6 Months    : 8
Insider 3/6 Months : 16.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arcutis Biotherapeutics is a late-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with unmet medical needs. Co.'s product candidate, topical roflumilast cream, is used for plaque psoriasis, including intertriginous psoriasis, as well as atopic dermatitis. Co. is developing a topical foam formulation of roflumilast for the treatment of scalp psoriasis and seborrheic dermatitis; ARQ-252, a topical cream formulation of a small molecule inhibitor of Janus kinase type 1 for chronic hand eczema and vitiligo; and ARQ-255, an alternative topical formulation of ARQ-252 designed to reach into the skin in order to treat alopecia areata.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 21,052 21,052 102,515 352,515
Total Buy Value $199,994 $199,994 $409,328 $5,409,328
Total People Bought 1 1 2 2
Total Buy Transactions 1 1 3 4
Total Shares Sold 29,378 32,553 35,988 497,679
Total Sell Value $325,434 $333,787 $359,367 $9,868,161
Total People Sold 4 4 4 10
Total Sell Transactions 5 7 9 55
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 194
  Page 3 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Watanabe Todd Franklin President and CEO   •       •      –    2022-03-03 4 A $0.00 $0 D/D 70,900 663,526     -
   Burrows Scott L Chief Financial Officer   •       –      –    2022-03-03 4 A $0.00 $0 D/D 13,300 35,559     -
   Moore Matthew Richard SVP and Chief Business Officer   •       –      –    2022-03-03 4 A $0.00 $0 D/D 13,300 13,300     -
   Osborne David W Chief Technical Officer   •       –      –    2022-03-03 4 A $0.00 $0 D/D 13,300 260,282     -
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-03 4 A $0.00 $0 D/D 13,300 32,136     -
   Lock Kenneth A. Chief Commercial Officer   •       –      –    2022-03-03 4 A $0.00 $0 D/D 13,300 45,034     -
   Matsuda Masaru SVP and General Counsel   •       –      –    2022-03-03 4 A $0.00 $0 D/D 13,300 13,300     -
   Burnett Patrick See Remarks   •       –      –    2022-03-03 4 A $0.00 $0 D/D 17,800 44,050     -
   Lock Kenneth A. Chief Commercial Officer   •       –      –    2022-03-01 4 AS $17.75 $16,599 D/D (935) 31,734 46%     
   Osborne David W Chief Technical Officer   •       –      –    2022-03-01 4 AS $17.75 $13,758 D/D (775) 246,982 46%     
   Burrows Scott L Chief Financial Officer   •       –      –    2022-03-01 4 AS $17.75 $7,456 D/D (420) 22,259 46%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-03-01 4 AS $17.75 $38,222 D/D (2,153) 592,626 46%     
   Turney Patricia A. SVP, Operations   •       –      –    2022-03-01 4 AS $17.75 $16,617 D/D (936) 18,836 46%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-02-09 4 AS $17.00 $17,000 D/D (1,000) 594,779 27%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-02-09 4 OE $1.68 $1,681 D/D 1,000 595,779     -
   Watanabe Todd Franklin President and CEO   •       •      –    2022-01-05 4 AS $21.11 $21,592 D/D (1,000) 594,779 -10%     
   Watanabe Todd Franklin President and CEO   •       •      –    2022-01-05 4 OE $1.68 $1,681 D/D 1,000 595,779     -
   Welgus Howard G. Director   –       •      –    2022-01-03 4 AS $21.21 $53,030 D/D (2,500) 181,896 -23%     
   Welgus Howard G. Director   –       •      –    2022-01-03 4 OE $0.58 $1,451 D/D 2,500 184,396     -
   Burnett Patrick See Remarks   •       –      –    2021-12-30 4 A $0.00 $0 D/D 16,750 26,250     -
   Burrows Scott L Chief Financial Officer   •       –      –    2021-12-27 4 AS $20.07 $252,139 D/D (12,560) 22,679 4%     
   Welgus Howard G. Director   –       •      –    2021-12-23 4 AS $20.16 $50,396 D/D (2,500) 181,896 9%     
   Welgus Howard G. Director   –       •      –    2021-12-23 4 OE $0.58 $1,451 D/D 2,500 184,396     -
   Watanabe Todd Franklin President and CEO   •       •      –    2021-12-08 4 AS $17.00 $17,000 D/D (1,000) 594,779 27%     
   Watanabe Todd Franklin President and CEO   •       •      –    2021-12-08 4 OE $1.68 $1,681 D/D 1,000 595,779     -
  194 Records found
  1  2  3  4  5  6  7  8   
  Page 3 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us